174 related articles for article (PubMed ID: 32185543)
1. CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells.
Wang L; Liang TT
AMB Express; 2020 Mar; 10(1):54. PubMed ID: 32185543
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
6. Micelle-contained and PEGylated hybrid liposomes of combined gemcitabine and cisplatin delivery for enhancing antitumor activity.
Liu Z; Chu W; Sun Q; Zhao L; Tan X; Zhang Y; Yin T; He H; Gou J; Tang X
Int J Pharm; 2021 Jun; 602():120619. PubMed ID: 33887396
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid-cisplatin-based liposomes.
Song J; Ren W; Xu T; Zhang Y; Guo H; Zhu S; Yang L
Drug Des Devel Ther; 2017; 11():441-449. PubMed ID: 28255230
[TBL] [Abstract][Full Text] [Related]
8. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
[TBL] [Abstract][Full Text] [Related]
9. Aptamer (AS1411)-Conjugated Liposome for Enhanced Therapeutic Efficacy of miRNA-29b in Ovarian Cancer.
Jiang L; Wang H; Chen S
J Nanosci Nanotechnol; 2020 Apr; 20(4):2025-2031. PubMed ID: 31492208
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
[TBL] [Abstract][Full Text] [Related]
11. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y
Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984
[No Abstract] [Full Text] [Related]
12. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
14. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
Liu B; Han L; Liu J; Han S; Chen Z; Jiang L
Int J Nanomedicine; 2017; 12():955-968. PubMed ID: 28203075
[TBL] [Abstract][Full Text] [Related]
16. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
17. Chitosan Nanolayered Cisplatin-Loaded Lipid Nanoparticles for Enhanced Anticancer Efficacy in Cervical Cancer.
Wang JY; Wang Y; Meng X
Nanoscale Res Lett; 2016 Dec; 11(1):524. PubMed ID: 27888498
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
[TBL] [Abstract][Full Text] [Related]
20. Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.
Liu P; Sun L; Zhou DS; Zhang P; Wang YH; Li D; Li QH; Feng RJ
Sci Rep; 2015 Dec; 5():17387. PubMed ID: 26619950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]